Value Base Ltd. Purchases New Stake in SHL Telemedicine Ltd. (NASDAQ:SHLT)

Value Base Ltd. bought a new stake in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) in the 4th quarter, Holdings Channel reports. The institutional investor bought 941,923 shares of the company’s stock, valued at approximately $2,496,000. SHL Telemedicine comprises about 1.5% of Value Base Ltd.’s investment portfolio, making the stock its 6th biggest holding. Value Base Ltd. owned approximately 0.06% of SHL Telemedicine at the end of the most recent quarter.

SHL Telemedicine Trading Down 4.7 %

Shares of SHLT stock opened at $2.38 on Friday. SHL Telemedicine Ltd. has a 12-month low of $2.03 and a 12-month high of $7.96. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.17 and a quick ratio of 1.98. The firm has a fifty day moving average of $2.54 and a 200-day moving average of $2.86.

SHL Telemedicine Company Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.